LEVETIRACETAM DEXCEL 500

Država: Izrael

Jezik: angleščina

Source: Ministry of Health

Aktivna sestavina:

LEVETIRACETAM

Dostopno od:

DEXCEL PHARMA TECHNOLOGIES LTD

Koda artikla:

N03AX14

Farmacevtska oblika:

TABLETS

Sestava:

LEVETIRACETAM 500 MG

Pot uporabe:

PER OS

Tip zastaranja:

Required

Izdeluje:

DEXCEL LTD, ISRAEL

Terapevtska skupina:

LEVETIRACETAM

Terapevtsko območje:

LEVETIRACETAM

Terapevtske indikacije:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Datum dovoljenje:

2018-03-31